Testing the validity of national drug surveys: comparison between a general population cohort and household surveys.


Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
08 2021
Historique:
revised: 26 07 2020
received: 02 06 2020
accepted: 02 12 2020
pubmed: 18 1 2021
medline: 30 9 2021
entrez: 17 1 2021
Statut: ppublish

Résumé

There are concerns that national population-based estimates of illicit drug use are underestimated. We investigated this by comparing estimates of illicit substance use at age 24 from the Crime Survey for England and Wales (CSEW) with a birth cohort (Avon Longitudinal Study of Parents and Children, ALSPAC) and by comparing the Smoking and Alcohol Toolkit Studies (STS/ATS) to ALSPAC. Cross-sectional household survey and cross-sectional data from one wave of a longitudinal birth cohort. England and Wales. Young adults aged 23-25 reporting on substance use in 2017 to CSEW (n = 1165), ALSPAC (n = 3389) and STS/ATS (n = 950). Lifetime and past-year illicit drug use, smoking status and hazardous drinking at age 24. The 2017 CSEW estimate of lifetime illicit drug use was 40.6%, compared with 62.8% in ALSPAC (risk difference % [RD%] = 22.2%; 95% CI = 18.9-25.5%; P ≤ 0.001). The RD in lifetime use between ALSPAC and the CSEW was 23.2% (95% CI = 20.0-26.4%) for cannabis, 16.9% (95% CI = 14.4-19.4%) for powder cocaine and 24.8% (95% CI = 22.6-27.0%) for amphetamine. Past-year drug use was 16.4% in CSEW, compared with 36.7% in ALSPAC (RD% = 20.3%; 95% CI = 17.6-23.0%; P ≤ 0.001). For past-year substance use, the RD between ALSPAC and the CSEW was 15.4% (95% CI = 12.9-17.9%) for cannabis, 14.8% (95% CI = 13.0%-16.6%) for powder cocaine and 15.9% (95% CI = 14.5-17.4%) for amphetamine. Levels of current smoking were similar between STS (27.4%) and ALSPAC (29.4%). Hazardous drinking was substantially higher in ALSPAC (60.3%) than the ATS (32.1%; RD% = 28.2%; 95% CI = 24.8-31.6%; P ≤ 0.001). The Avon Longitudinal Study of Parents and Children provides one source of validation for measurements of drug use in government household surveys and indicates that illicit drug use may be underestimated in the Crime Survey for England and Wales.

Sections du résumé

BACKGROUND AND AIMS
There are concerns that national population-based estimates of illicit drug use are underestimated. We investigated this by comparing estimates of illicit substance use at age 24 from the Crime Survey for England and Wales (CSEW) with a birth cohort (Avon Longitudinal Study of Parents and Children, ALSPAC) and by comparing the Smoking and Alcohol Toolkit Studies (STS/ATS) to ALSPAC.
DESIGN
Cross-sectional household survey and cross-sectional data from one wave of a longitudinal birth cohort.
SETTING
England and Wales.
PARTICIPANTS
Young adults aged 23-25 reporting on substance use in 2017 to CSEW (n = 1165), ALSPAC (n = 3389) and STS/ATS (n = 950).
MEASUREMENTS
Lifetime and past-year illicit drug use, smoking status and hazardous drinking at age 24.
FINDINGS
The 2017 CSEW estimate of lifetime illicit drug use was 40.6%, compared with 62.8% in ALSPAC (risk difference % [RD%] = 22.2%; 95% CI = 18.9-25.5%; P ≤ 0.001). The RD in lifetime use between ALSPAC and the CSEW was 23.2% (95% CI = 20.0-26.4%) for cannabis, 16.9% (95% CI = 14.4-19.4%) for powder cocaine and 24.8% (95% CI = 22.6-27.0%) for amphetamine. Past-year drug use was 16.4% in CSEW, compared with 36.7% in ALSPAC (RD% = 20.3%; 95% CI = 17.6-23.0%; P ≤ 0.001). For past-year substance use, the RD between ALSPAC and the CSEW was 15.4% (95% CI = 12.9-17.9%) for cannabis, 14.8% (95% CI = 13.0%-16.6%) for powder cocaine and 15.9% (95% CI = 14.5-17.4%) for amphetamine. Levels of current smoking were similar between STS (27.4%) and ALSPAC (29.4%). Hazardous drinking was substantially higher in ALSPAC (60.3%) than the ATS (32.1%; RD% = 28.2%; 95% CI = 24.8-31.6%; P ≤ 0.001).
CONCLUSIONS
The Avon Longitudinal Study of Parents and Children provides one source of validation for measurements of drug use in government household surveys and indicates that illicit drug use may be underestimated in the Crime Survey for England and Wales.

Identifiants

pubmed: 33455031
doi: 10.1111/add.15371
pmc: PMC8359398
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2076-2083

Subventions

Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : British Heart Foundation
ID : MR/KO232331/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 209158/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L022206/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : 102215/2/13/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C1417/A22962
Pays : United Kingdom
Organisme : Alcohol Research UK
ID : MR/L022206/1

Informations de copyright

© 2021 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Références

Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Addiction. 1995 Mar;90(3):391-405
pubmed: 7735023
Epidemiology. 2010 May;21(3):383-8
pubmed: 20335814
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
JAMA Netw Open. 2019 Aug 2;2(8):e1910161
pubmed: 31461148
Int J Epidemiol. 2018 Apr 1;47(2):587-596
pubmed: 29088358
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
BMC Public Health. 2015 Mar 07;15:230
pubmed: 25884652
Public Health Rev. 2014;35(2):
pubmed: 28366975
BMC Public Health. 2018 Mar 21;18(1):391
pubmed: 29562901
PLoS One. 2018 Aug 16;13(8):e0202502
pubmed: 30114272
BMC Public Health. 2011 Jun 18;11:479
pubmed: 21682915
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Addiction. 2021 Aug;116(8):2076-2083
pubmed: 33455031
Subst Abuse. 2017 Jun 30;11:1178221817716391
pubmed: 28924351
Addiction. 2018 Oct;113(10):1905-1926
pubmed: 29749059
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743

Auteurs

Hannah Charles (H)

National Infection Service, Public Health England, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Jon Heron (J)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Matthew Hickman (M)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Jamie Brown (J)

Department of Behavioural Science and Health, University College London, London, UK.

Lindsey Hines (L)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH